default author photo

Kwok-Hung Chan

The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases

SCHOLARLY PAPERS

4

DOWNLOADS

664

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Boosting of Serum Neutralizing Activity Against the Omicron Variant Among Recovered COVID-19 Patients by BNT162b2 and Coronavac Vaccines

Number of pages: 36 Posted: 08 Feb 2022
Lu Lu, Lin-Lei Chen, Ricky Rui-Qi Zhang, Owen Tak-Yin Tsang, Jacky Man-Chun Chan, Anthony Raymond Tam, Wai-Shing Leung, Thomas Shiu-Hong Chik, Daphne Pui-Ling Lau, Chris Yau-Chung Choi, Carol Ho-Yan Fong, Jian-Piao Cai, Hoi-Wah Tsoi, Charlotte Yee-Ki Choi, Xiaojuan Zhang, Syed Muhammad Umer Abdullah, Brian Pui-Chun Chan, Kwok-Hung Chan, Kwok-Yung Yuen, Ivan Fan Ngai Hung and Kelvin Kai-Wang To
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Li Ka Shing Faculty of Medicine, Princess Margaret Hospital - Department of Medicine, The University of Hong Kong, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, Southern Medical University - Division of Laboratory Medicine, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 421 (172,704)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Omicron variant, Neutralizing antibody, Surrogate neutralizing antibody test, spike protein receptor binding domain, Variants of Concern

2.

Effect of Vaccine Booster, Vaccine Type, and Hybrid Immunity on Humoral and Cellular Immunity Against SARS-CoV-2 Ancestral Strain and Omicron Variant Sublineages BA.2 and BA.5 Among Older Adults with Comorbidities: An Observational Study

Number of pages: 29 Posted: 14 Sep 2022
Carol Ho-Yan Fong, Xiaojuan Zhang, Lin-Lei Chen, Rosana Wing-Shan Poon, Brian Pui-Chun Chan, Yan Zhao, Carlos Wong, Kwok-Hung Chan, Kwok-Yung Yuen, Ivan Fan Ngai Hung, Jacqueline Kwan Yuk Yuen and Kelvin Kai-Wang To
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Department of Family Medicine and Primary Care, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - School of Clinical Medicine, The University of Hong Kong - Division of Geriatrics and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 116 (613,149)

Abstract:

Loading...

COVID-19, SARS-CoV-2, older adults, vaccine booster, neutralizing antibody, T cell response, hybrid immunity

3.

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal Delns1-nCoV-RBD LAIV for COVID-19 in Healthy Adults

Number of pages: 32 Posted: 20 Jun 2022
Ricky Rui-Qi Zhang, Kwok-Hung Chan, Pui Wang, Runhong Zhou, Henry Kwong-Chi Yau, Creany Ka-Wai Wong, Meena Wai-Lam Au, Anthony Raymond Tam, Chi-Tao Ng, Matthew Kwok-Chung Lou, Na Liu, Haode Huang, Shaofeng Deng, Chun-Yee Tam, Ying Liu, Teng Long, Hoi-Wah Tsoi, Miko KW Ng, Jian-Piao Cai, Kelvin Kai-Wang To, Man-Fung Yuen, Zhiwei Chen, Honglin Chen, Kwok-Yung Yuen and Ivan Fan Ngai Hung
The University of Hong Kong - Li Ka Shing Faculty of Medicine, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - AIDS Institute, The University of Hong Kong - AIDS Institute, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Queen Mary Hospital, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases and The University of Hong Kong - School of Clinical Medicine
Downloads 75 (837,727)

Abstract:

Loading...

Phase-1, intranasal, DelNS1-nCoV-RBD LAIV, COVID-19

4.

The Impact of Vaccine Type and Booster Dose on the Magnitude and Breadth of Sars-Cov-2-Specific Mucosal Iga

Number of pages: 28 Posted: 15 May 2024
Hoi-Wah Tsoi, Miko Ka-Wai Ng, Jian-Piao Cai, Rosana Wing-Shan Poon, Brian Pui-Chun Chan, Kwok-Hung Chan, Anthony Raymond Tam, Wing-Ming Chu, Ivan Fan Ngai Hung and Kelvin Kai-Wang To
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, Government of the Hong Kong Special Administrative Region - Hospital Authority, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 52 (1,041,696)

Abstract:

Loading...

COVID-19 vaccine, SARS-CoV-2, Omicron variant, mucosal immunity, saliva, IgA